Eam Investors, LLC Clearside Biomedical, Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$2.72 - $5.72 $673,365 - $1.42 Million	-247,561 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.32 - $5.38 $574,341 - $1.33 Million	247,561 New	247,561 $1.21 Million
Q2 2018 Aug 03, 2018	SELL	$8.91 - $14.54 $2.67 Million - $4.35 Million	-299,111 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$5.57 - $14.28 $1.67 Million - $4.27 Million	299,111 New	299,111 $3.21 Million

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $52.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.